ZNF441
Zinc finger protein 441
Also known as: FLJ38637, ZN441_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N8Z8
- Gene
- ZNF441
- Ensembl
- ENSG00000197044
- Chromosome
- 19
- Canonical length
- 693 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nuclear speckles
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
693 residues, UniProt reviewed canonical sequence.
>Q8N8Z8|ZNF441
1 MDSVAFEDVA INFTCEEWAL LGPSQKSLYR DVMQETIRNL DCIGMIWQNH DIEEDQYKDL
61 RRNLRCHMVE RACEIKDNSQ CGGPFTQTQD SIVNEKIPGV DPWESSECTD VLMGRSSLNC
121 YVRVDSEHKP CEYQEYGEKP YTHTQCGTAF SYQPCFQIHE RPQHGKKLYD CKECASFSSL
181 ENLQRHMAAH HGDGPRICKL CGNAFIWPSL FHMLRRTHTE EKPYEYEQCS TAFPAYSSTL
241 RHERTHSGEK PYQCKQCGKA FSCSCYTQLY ERTHTGEQSY ECKQCGKAFY HLGSFQRHMI
301 VHTGDGPHKC KICGKGFLSP SSVRRHKRTH TGEKPYECKY CGKAFSDCTG FRRHMITHTG
361 DGPHKCKVCG KAFDSPSLCR RHETTHTGEK PYKCECGKAF SDFYYFRNHE TTHTGEKPYK
421 CKQCGKAFIC CTYLQIHERI HTGERPYKCK QCGKAFRSSN YIRVHEKTHT GEKPYECKQC
481 GKALSHLKSF QRHMIMHTGD GPHKCKICGK SFDSPSSFRR HERIHTGERP YKCKLCGKGF
541 RSSSYIQLHE RTHTGEKPYG CQQCGKALSD LSSFRRHMIT HTGNGPHKCK ICGKGFDYPS
601 SVQRHERTHT GEKPYECKEC GKAFSHSSYL RIHERVHTGE KPYKCKECGK PFHCPSAFHK
661 HERTHSMEKP YKCKECGEAF HCISSFHKHE MTHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF441 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 8.4 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 8.4 nTPM
- parathyroid gland: 6.8 nTPM
- pituitary gland: 6.6 nTPM
- retina: 6.6 nTPM
- thyroid gland: 6.6 nTPM
- basal ganglia: 6.5 nTPM
Single-cell type
- myonuclei: 44 nCPM
- bergmann glia: 37 nCPM
- tuft cells: 35 nCPM
- lactotrophs: 33 nCPM
- rod photoreceptor cells: 33 nCPM
- thyrotrophs: 27 nCPM
Immune cell
- naive B-cell: 1.6 nTPM
- naive CD8 T-cell: 1.6 nTPM
- non-classical monocyte: 1.6 nTPM
- memory CD8 T-cell: 1.5 nTPM
- memory B-cell: 1.4 nTPM
- naive CD4 T-cell: 1.4 nTPM
Brain region
- cerebellum: 18 nTPM
- basal ganglia: 12 nTPM
- cerebral cortex: 12 nTPM
- white matter: 12 nTPM
- hypothalamus: 11 nTPM
- amygdala: 11 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.01
- gnomAD pLI
- 0.36
- gnomAD missense Z
- 1.56
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF441 as an antibody target. Whether an autoantibody or antibody against ZNF441 could matter depends on whether native ZNF441 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF441 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF441 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...